Transmedics Group Inc (NASDAQ:TMDX)’s traded shares stood at 0.57 million during the latest session, with the company’s beta value hitting 2.07. At the last check today, the stock’s price was $68.68, to imply an increase of 3.67% or $2.43 in intraday trading. The TMDX share’s 52-week high remains $177.37, putting it -158.26% down since that peak but still an impressive 3.76% since price per share fell to its 52-week low of $66.10. The company has a valuation of $2.31B, with an average of 2.1 million shares in intraday trading volume over the past 10 days and average of 1.73 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Transmedics Group Inc (TMDX), translating to a mean rating of 1.56. Of 7 analyst(s) looking at the stock, 0 analyst(s) give TMDX a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.15.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Transmedics Group Inc (NASDAQ:TMDX) trade information
After registering a 3.67% upside in the latest session, Transmedics Group Inc (TMDX) has traded red over the past five days. The 5-day price performance for the stock is -20.79%, and -20.46% over 30 days. With these gigs, the year-to-date price performance is -12.99%. Short interest in Transmedics Group Inc (NASDAQ:TMDX) saw shorts transact 8.98 million shares and set a 4.25 days time to cover.
The extremes give us $109 and $180 for target low and target high price respectively. As such, TMDX has been trading -162.09% off suggested target high and -58.71% from its likely low.
Transmedics Group Inc (TMDX) estimates and forecasts
Looking at statistics comparing Transmedics Group Inc share performance against respective industry, we note that the company has outperformed competitors. Transmedics Group Inc (TMDX) shares are -49.93% down over the last 6 months, with its year-to-date growth rate higher than industry average at 229.87% against 16.60%. The rating firms project that company’s revenue will grow 78.43% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is 110.79M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 123.77M.Earnings reports from the last fiscal year show that sales brought in 81.17M and 96.85M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 36.48% before jumping 27.80% in the following quarter.
TMDX Dividends
Transmedics Group Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Transmedics Group Inc (NASDAQ:TMDX)’s Major holders
Transmedics Group Inc insiders hold 3.18% of total outstanding shares, with institutional holders owning 112.92% of the shares at 116.63% float percentage. In total, 112.92% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 4.49 million shares (or 13.7063% of shares), all amounting to roughly $676.31 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 2.65 million shares, or about 8.0755% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $398.47 million.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Transmedics Group Inc (TMDX) shares. Going by data provided on Sep 30, 2024, Vanguard Total Stock Market Index Fund holds roughly 1.02 shares. This is just over 3.04% of the total shares, with a market valuation of $70.08 million. Data from the same date shows that the other fund manager holds a little less at 832.29, or 2.48% of the shares, all valued at about 57.2 million.
